Correlation Engine 2.0
Clear Search sequence regions


  • adenocarcinomas (1)
  • adenomas (1)
  • adult (2)
  • argon (9)
  • cancer (3)
  • EMR (12)
  • female (1)
  • humans (1)
  • hybrid (8)
  • lymph node (1)
  • margins (1)
  • metastasis (1)
  • patients (4)
  • plasma (1)
  • polyp size (1)
  • polyps (6)
  • women (1)
  • Sizes of these terms reflect their relevance to your search.

    EMR is the mainstay of therapy for large colorectal polyps. Local recurrence after EMR is common and can be reduced using margin ablation. Our aim was to evaluate recurrence rates when using hybrid argon plasma coagulation (h-APC) ablation after EMR. Adult patients (aged 18-89 years) undergoing EMR of nonpedunculated colorectal polyps ≥20 mm were enrolled in a prospective multicenter study. h-APC was used to ablate all defect margins and also the resection surface in selected cases. The primary study outcome was recurrence rates found during the first follow-up colonoscopy. Secondary outcomes were technical success and adverse event rates. EMR with h-APC ablation was used in 101 polyps (84 patients, 46.4% women). EMR with h-APC ablation was technically successful in all cases (median EMR time, 15 minutes; median h-APC ablation time, 4 minutes). Median polyp size was 30 mm (range, 20-60). Resected polyps were either adenomas (68/101 [67.3%]), sessile serrated lesions (27/101 [27%]), or adenocarcinomas (6/101 [6%]). The post-EMR recurrence rate was 2.2% (2/91) (95% confidence interval, .27-7.71). All 6 patients with cancer (intramucosal cancer, 4; T1sm cancer, 2) were found to have complete eradication of the primary tumor after EMR with h-APC, and none had lymph node metastasis. Four serious adverse events occurred in 3 patients (2 delayed bleeding [2.4%], 1 abdominal pain [1.2%], and 1 microperforation [1.2%]. All serious adverse events resolved with either endoscopic or antibiotic treatment only. EMR with h-APC showed a high technical success rate, low adverse event rate, and very low post-EMR recurrence rates. (Clinical trial registration number: NCT04015765.). Copyright © 2022 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

    Citation

    Leslie Motchum, John M Levenick, Roupen Djinbachian, Matthew T Moyer, Simon Bouchard, Mahsa Taghiakbari, Alessandro Repici, Érik Deslandres, Daniel von Renteln. EMR combined with hybrid argon plasma coagulation to prevent recurrence of large nonpedunculated colorectal polyps (with videos). Gastrointestinal endoscopy. 2022 Nov;96(5):840-848.e2

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 35724695

    View Full Text